n,n-dimethylarginine has been researched along with Leukemia, Myeloid, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biedroń, M; Butrym, A; Chachaj, A; Fleszar, MG; Gamian, A; Karczewski, M; Krzystek-Korpacka, M; Mazur, G; Rybka, J; Szuba, A; Wiśniewski, J; Wróbel, T | 1 |
| Hämäläinen, S; Jantunen, E; Juutilainen, A; Koivula, I; Lappalainen, M; Pulkki, K | 1 |
2 other study(ies) available for n,n-dimethylarginine and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Biomarkers, Tumor; Case-Control Studies; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Prospective Studies; Survival Rate; Young Adult | 2018 |
Asymmetric dimethylarginine in the assessment of febrile neutropenia in hematological patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Arginine; Bacteremia; Biomarkers; C-Reactive Protein; Febrile Neutropenia; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Prospective Studies; Shock, Septic; Stem Cell Transplantation; Transplantation, Autologous | 2017 |